Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Gynecol Oncol. 2019 Jul 25;154(3):524–530. doi: 10.1016/j.ygyno.2019.07.004

Table 2.

Change From baseline scores (TP0) on quality of life measures (N=23)

Variable Visit N Mean (95% CI) P-value*

CESD TP1 21 −8.88 (−13.90, −3.86) 0.009
TP2 18 −11.12 (−17.43, −4.81) 0.010
FACT EWB TP1 18 2.42 (−0.08, 4.93) 0.097
TP2 15 3.27 (0.84, 5.69) 0.045
FACT FWB TP1 18 1.62 (−0.47, 3.71) 0.197
TP2 15 1.87 (−0.85, 4.60) 0.232
FACT PWB TP1 19 2.61 (−1.35, 6.58) 0.238
TP2 16 3.38 (−0.51, 7.28) 0.213
FACT SWB TP1 16 −0.78 (−3.34, 1.78) 0.591
TP2 14 −1.59 (−4.18, 1.00) 0.273
FACT-G Total TP1 14 3.84 (−3.12, 10.81) 0.239
TP2 12 5.71 (−0.87, 12.28) 0.220
FACT-O Total TP1 14 9.22 (−0.42, 18.86) 0.186
TP2 12 12.46 (5.50, 19.41) 0.034
HADS Anxiety TP1 20 −1.80 (−3.59, −0.01) 0.117
TP2 17 −3.24 (−5.44, −1.03) 0.036
HADS Depression TP1 19 −1.16 (−3.34, 1.02) 0.273
TP2 18 −2.11 (−3.75, −0.48) 0.045
*

False discovery rate–adjusted signed rank test P-values.